Achieving value in the NHS through partnership
How AbbVie’s ‘Decisions with Value’ initiative brought healthcare experts together to tackle the challenge of improving health outcomes while making savings. Over recent years the NHS...
Advancing electronic prescribing
The Electronic Prescription Service (EPS) sends electronic prescriptions from GP surgeries to pharmacies and currently accounts for around 64% of all prescriptions issued in...
Medicines Discovery Catapult and the high impact medicines discovery
Chris Molloy is the Chief Executive Officer of the Medicines Discovery Catapult (MDC). He joined the organisation two years ago as only the second...
Doctors of the World: Healthcare for everyone
Lucy Jones, Director of Programmes at Doctors of the World UK, supports access to healthcare for excluded people around the world. She joined the...
Managing the menopause at work
Every woman will go through the menopause, so why is it rarely discussed openly in a work environment? A significant cultural shift is required in...
Uniting traditional and digital marketing
Dmitry Schourov is Strategy and Commercial Operations Director at Pfizer Russia, responsible for full strategic support of the business and all operational support including...
Rise of the biosimilars
2018 was a significant year for biosimilars. October’s patent expiry of adalimumab, the world’s top selling prescription medicine, saw a raft of biosimilars launch,...
Politics and the NHS Long Term Plan
Claudia Rubin looks at the immediate political response to the NHS 10 Year Plan which launched in January. Politics always moves at an incredible pace as...
PPRS evolution and what does it mean for pharma?
How has the Pharmaceutical Price Regulation Scheme (PPRS) evolved since its inception in the 1950s, and what does its latest iteration mean for pharma? Price...
What is the future of cancer?
4 February is World Cancer Day.
It’s a commonly discussed disease with well-publicised media campaigns around causes and symptoms, but it still affects more...
Latest articles
Changes to GSK sales representative incentive programme
GSK has announced changes to its sales representative incentive programme for representatives in certain countries. These changes reflect the growing shift in GSK’s portfolio...
Peer-to-peer mental health support app goes live
The UK's first free peer-to-peer mental health support app, 'Unmasked', has gone live after a period of extensive testing. The brainchild of three Yorkshiremen, Logan...
Drug firms accused of illegal market sharing over anti-nausea tablets
The Competitions and Markets Authority (CMA) has accused four pharmaceutical companies of illegal market sharing over anti-nausea tablets. The CMA has provisionally found that the pharmaceutical...
Popular articles
Peer-to-peer mental health support app goes live
The UK's first free peer-to-peer mental health support app, 'Unmasked', has gone live after a period of extensive testing. The brainchild of three Yorkshiremen, Logan...
NICE issues final guidance for Tegsedi ®▼
Akcea Therapeutics UK Ltd, an affiliate of Akcea Therapeutics, Inc announced that the National Institute for Health and Care Excellence (NICE) has published its...
Nurofen launches a 24 hour ibuprofen pain relief patch
Nurofen announces the launch of the UK’s only 24 hour clinically proven pain relief patch containing ibuprofen. Despite body pain being among the most commonly...
Changes to GSK sales representative incentive programme
GSK has announced changes to its sales representative incentive programme for representatives in certain countries. These changes reflect the growing shift in GSK’s portfolio...
Wasdell Group expands portfolio with Honeywood acquisition
The Wasdell Group (Wasdell), a leading outsourcing partner for companies in the pharmaceutical industry, has announced its acquisition of Honeywood Limited, a specialist manufacturer...